|
Thursday, 01 November 2007 |
|
GlaxoSmithKline Consumer Healthcare is continuing its focus on the Beechams brand with the launch of Beechams Active Cold Relief Caplets which they expect to add incremental value to the category.
 Designed for those who feel that a cold or flu has left them with a foggy head, Beechams Active Cold Relief Caplets can help your customers to actively fight their cold symptoms – so they can think clearly again.
Containing paracetamol, caffeine and a decongestant, they provide effective relief from the major cold and flu symptoms in a convenient and easy to swallow tablet.
Packaged in a tough, crush-resistant, ‘compack’ wallet pack which can be carried in a pocket or handbag, Beechams Active Cold Relief Caplets are ideal for those specific times when people need to get on despite a cold.
The packs, which have distinctive rounded edges, click open to reveal both the patient information and the product conveniently integrated into one plastic structure.
Beechams Active Cold Relief Caplets command a premium recommended selling price of £3.49 for 14 caplets (GSL). They contain paracetamol (500 mg), caffeine (25 mg) and phenylephrine hydrochloride (5 mg).
 Similar news items:
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
|
Show/Hide comments
Show/Hide comment form
© Nexus Business Media Limited 2008